Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Cyclosporin is effective for treating skin conditions in small animals, but requires careful dosing and monitoring for side effects.

Teloptosis is a key point in hair loss that could help in creating prevention-focused hair care strategies.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Pegvaliase effectively reduces blood phenylalanine levels in most PKU patients, but requires personalized plans and good communication to manage side effects.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Dianabol boosts muscle growth but has serious health risks and legal issues.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

Eflornithine's effectiveness for women with facial hirsutism is unclear.

Low-level laser therapy safely and effectively improves hair growth and coverage for male and female pattern hair loss.

PRP injections may slightly improve hair density and count for male hair loss, but more research is needed.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Finasteride improves hair growth in men with androgenetic alopecia.

Minoxidil treats high blood pressure and side effects can be managed.

Minoxidil can cause dangerous fluid buildup around the heart.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Caesalpinia bonduc seed extracts may help treat enlarged prostate in rats.

Ishige sinicola extract helps bone-building cells grow and mature, which could aid in treating osteoporosis.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

Most people in the surveyed area experience hair loss, but they are not aware of the role of diet, iron, hormones, genetics, and possibly water quality in causing it.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

Multiple treatments work best for hair loss.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.